Innate Pharma SA (IPHA)
2.22
-0.01
(-0.45%)
USD |
NASDAQ |
Aug 28, 16:00
2.23
+0.01
(+0.45%)
After-Hours: 20:00
Innate Pharma Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 588.44M |
| Cellectis SA | 279.81M |
| Genfit SA | -- |
| Inventiva SA | 857.79M |
Enterprise Value Related Metrics
| Earnings Yield | -27.68% |
| Normalized Earnings Yield | -27.98 |